- Series 2017A revenue bonds
- Series 2017B revenue bonds
- Series 2017C revenue bonds
- Series 2015A revenue bonds
- Series 2011A revenue bonds
- Series 2009A revenue bonds
The outlook is positive, reflecting the cancer center’s strengthening balance sheet in fiscal year 2016 and the subsequent liquidation of a portion of its stock in Seattle-based Juno Therapeutics, which bolstered the cancer center’s cash and investments during the past two fiscal years.
More articles on healthcare finance:
S&P places MetroHealth System’s ‘A-‘ bonds on CreditWatch
S&P lowers North Oaks Health System’s rating to ‘BB+’ on select bonds
Fitch assigns ‘AA-‘ rating to University Medical Center of El Paso’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
